Blood

Vol. 147, Issue 22 Issue 22 2026
18
Articles

Articles in this Issue

Cracking the CODEX of the leukemic BM microenvironment

Delfim Duarte May 28, 2026 pp. 2564-2565 10.1182/blood.2026033251

CSNK1E sustains stemlike drug persistence in diffuse large B-cell lymphoma

Xiang Li, Mengke Liu, Qing Shi et al. May 28, 2026 pp. 2633-2647 10.1182/blood.2025031156

Abstract Relapsed or refractory (R/R) disease occurs in up to 40% of patients with diffuse large B-cell lymphoma (DLBCL) following first-line immunochemotherapy. However, the molec...

A reassessment of anti–CAR T-cell expansion strategies

Catherine M. Bollard, Helen E. Heslop May 28, 2026 pp. 2561-2562 10.1182/blood.2026033564

Antigen-boosted CD4CAR T cells fail to expand or control viremia in multiple nonhuman primate models of HIV

Lucy H. Maynard, Carly E. Starke, Nikhita H. Poole et al. May 28, 2026 pp. 2621-2632 10.1182/blood.2025032142

Abstract Chimeric antigen receptor T (CAR T)-cell therapy has demonstrated curative potential in B-cell malignancies; yet, translating this success to chronic infections such as HI...

Morphologic and flow cytometric features of menin inhibitor–induced pseudoprogression in <i>KMT2A</i> -rearranged acute myeloid leukemia

Sarah R. Helman, Aaron J. Stonestrom May 28, 2026 pp. 2697-2697 10.1182/blood.2025033039

The GATA1 N terminus coordinates metabolic reprogramming in erythropoiesis

Te Ling, Lavanya Bezavada, Rashid Mehmood et al. May 28, 2026 pp. 2666-2681 10.1182/blood.2025030464

Abstract Mutations in GATA1 that cause skipping of exon 2, which encodes the N terminus, are associated with the myeloid leukemia of Down syndrome and Diamond-Blackfan anemia (DBA)...

Unlocking the locking secret behind FNAlT

Barry S. Coller May 28, 2026 pp. 2557-2558 10.1182/blood.2026033561

CD117-targeted HCT preconditioning in AML and MDS

Markus G. Manz May 28, 2026 pp. 2559-2560 10.1182/blood.2026033642

How I treat HLH-like toxicities after immune effector cell therapy

William T. Johnson, Kevin O. McNerney, Matthew J. Frank et al. May 28, 2026 pp. 2592-2609 10.1182/blood.2025032352

Abstract Breakthroughs in cancer immunotherapy have redefined patient care, ushering in a new era of therapeutic modalities, chimeric antigen receptor T cells (CAR-T), and bispecif...

Thrombotic thrombocytopenic purpura: celebrating 25 years of ADAMTS13

Marie Scully, Matthew A. Carter, Maryam Subhan May 28, 2026 pp. 2582-2591 10.1182/blood.2025030791

Abstract Thrombotic thrombocytopenic purpura (TTP) was first described just over a century ago, and it is now 25 years since the identification of ADAMTS13 as the enzyme deficient...

Clusterin maintains hemostatic equilibrium by stabilizing VWF multimers in plasma

Ziqi Qiao, Yang Cao, Jingge Su et al. May 28, 2026 pp. 2682-2696 10.1182/blood.2025030643

Abstract The coagulation-anticoagulation balance is tightly regulated by endothelial-derived factors, which have not been clearly defined. Here, we report that clusterin, a compone...

High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression

Lanzhu Li, Isabelle Rottmann, Borhan R. Saeed et al. May 28, 2026 pp. 2648-2665 10.1182/blood.2025029824

Abstract The bone marrow microenvironment (BMME) is essential for hematopoiesis and immunity, yet spatiotemporal single-cell analysis during leukemogenesis remains challenging. We...

Structural basis of HPA-1a alloimmunization in FNAIT and allosteric regulation of integrin conformation

Heng Zhang, Cathy Paddock, Janita J. Oosterhoff et al. May 28, 2026 pp. 2569-2581 10.1182/blood.2025032546

Abstract Fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be caused by maternal immunoglobulin G alloantibodies against the human platelet antigen 1a (HPA-1a), a Leu33Pro...

Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS

Lori Muffly, Catherine J. Lee, Arpita Gandhi et al. May 28, 2026 pp. 2610-2620 10.1182/blood.2025031858

Abstract Briquilimab is a monoclonal antibody inhibiting stem cell factor (SCF) binding to CD117 (c-Kit). Based on preclinical data demonstrating the antibody clears hematopoietic...

CSNK1E as a key to unlocking drug persistence in DLBCL

Gero Knittel, Hans Christian Reinhardt May 28, 2026 pp. 2562-2563 10.1182/blood.2026033531

Rust BJ, Kean LS, Colonna L, Brandenstein KE, Poole NH, Obenza W, Enstrom MR, Maldini CR, Ellis GI, Fennessey CM, Huang M-L, Keele BF, Jerome KR, Riley JL, Kiem H-P, Peterson CW. Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates. <i>Blood</i> . 2020;136(15):1722-1734.

May 28, 2026 pp. 2698-2698 10.1182/blood.2026033814

GATA have it: another pathway regulated by GATA1

David M. Bodine May 28, 2026 pp. 2565-2566 10.1182/blood.2025033020

Novel functions of WPB proteins seem to cluster with VWF

Christopher J. Ng May 28, 2026 pp. 2566-2567 10.1182/blood.2025032846

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page